Companies: 10,795·Total market cap: $144.5T
AtriCure, Inc.

AtriCure, Inc.

ATRCNASDAQHealthcare● Active
$26.92
$-0.19(-0.68%)
Market Cap$1.4B
P/E Ratio
52W High$43.18
52W Low$25.36

AtriCure, Inc. (ATRC) Stock Forecast & Analyst Price Target

Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.

atrc · stock forecast · 19 analysts (3M) · FMP · updated Jun 8, 2026

Analyst Rating & Consensus

Based on 19 Wall Street analysts in the past 3 months

SellBuy

Buy

19 analysts

consensus

Rating Breakdown

Strong Buy
0
Buy
18
Hold
1
Sell
0
Strong Sell
0
Total: 19 · Buy rate: 94.7%

12-Month Price Target

High

$55.00

Consensus

$51.33

+89.1% upside

Low

$44.00

Median: $55 · Last Close: $27.15

The AtriCure, Inc. (ATRC) analyst consensus is Buy, based on ratings from 19 Wall Street analysts over the past 3 months. The average 12-month ATRC price target is $51.33, representing +89.1% upside from the current price of $27.15.

12-Month Price Target Forecast

Historical closing prices + analyst 12-month price target forecast cone

Historical priceConsensus $51 (89.1%)

Consensus Target

$51.33

89.1% upside

High Target

$55

102.6%

Low Target

$44

62.1%

Current Price

$27.15

as of today

Based on analyst price targets, the ATRC stock price prediction for the next 12 months ranges from $44 to $55. The consensus ATRC price forecast of $51.33 implies 89.1% upside from the current price of $27.15.

Short-Term Price Prediction

Algorithmically generated · Updated daily

DatePredicted PriceChange
2026-06-09$26.592.05%

1-day model range: $26.46–$26.72. Peak: $26.72 (-2.05%).

Long-Term Stock Price Prediction

Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031

YearAvg PriceChange
2027$19-29.3%
2028$16-40.7%
2029$15-46.0%
2030$14-48.6%
2031-50.0%
Confidence:Medium

Stock Forecast Based on Technical Analysis

14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency

Market Sentiment

BEARISH

Based on 14 technical indicators

14%7%79%
2Buy
1Neutral
11Sell
RSI (14)41.3Neutral
MACDBEARISH

Refreshes daily from EOD close

Moving Averages · ATRC · Jun 8, 2026

Simple Moving Average (SMA)
MA 5$26.72BUY
MA 10$27.21SELL
MA 20$27.57SELL
MA 50$28.13SELL
MA 100$30.82SELL
MA 200$33.80SELL
Current $ATRC · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$27.02BUY
EMA 10$27.19SELL
EMA 20$27.51SELL
EMA 50$28.48SELL
EMA 100$30.27SELL
EMA 200$32.04SELL
Current $ATRC · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

Latest Analyst Ratings & Upgrades

Filter:
Canaccord Genuity2026-05-06
Maintains
BuyBuy
UBS2026-02-18
Maintains
BuyBuy
Citizens2026-02-18
Maintains
Market OutperformMarket Outperform
Canaccord Genuity2026-02-18
Maintains
BuyBuy
BTIG2026-02-18
Maintains
BuyBuy
Oppenheimer2026-02-18
Downgrade ↓
OutperformPerform
Needham2026-02-12
Maintains
BuyBuy
JP Morgan2025-12-16
Maintains
OverweightOverweight
Canaccord Genuity2025-10-30
Maintains
BuyBuy
Needham2025-07-30
Maintains
BuyBuy

Wall Street analysts have recently issued updated ratings on AtriCure, Inc. (ATRC) stock. Of the recent 148 rating actions, 7 were upgrades and 6 were downgrades. 19 analysts currently cover ATRC.

Analyst Recommendation Trends

Buy ratings514
Hold ratings00
Sell ratings00

ATRC analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 5 to 1 per month.

Financial Forecast: EPS & Revenue Estimates

Revenue This Year

$605M

↓ 20.7% YoY

Revenue Next Year

$678M

↑ 12.0% YoY

EPS This Year

$0.04

EPS Next Year

$0.35

↑ 840.0% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast ATRC EPS of $0.04 for the current fiscal year, based on estimates from 6 analysts. The ATRC revenue forecast is $605M for the current year. These are analyst consensus estimates via FMP / S&P Global.

About Forecast & Price Prediction

The ATRC stock forecast is supported by two independent data sources: analyst consensus ratings from 19 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus ATRC price target is $51.33 (+89.1% upside), with an analyst consensus of Buy.

The ATRC short-term stock prediction for tomorrow is $26.59 (-2.05%). The ATRC stock price prediction for 2027 estimates an average of $19. The ATRC stock prediction for 2030 projects a range of $13–$15.

AtriCure, Inc. trades on NASDAQ under the ticker ATRC. The ATRC stock outlook for 2027 is broadly positive, supported by a Buy consensus among 95% of covering analysts.

FAQ answers synthesize analyst targets, estimates, and on-page model outputs where shown.

Frequently asked questions

ATRC forecast · 8 questions

According to 19 Wall Street analysts, the average 12-month ATRC price target is $51.33, with a high forecast of $55.00 and a low of $44.00. The median price target is shown in the chart above when available. This implies +89.1% potential upside from the current price of $27.15.

ATRC price targetWhat is ATRC price targetATRC analyst price targetATRC 12-month target

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.